Detalhe da pesquisa
1.
Impact of COVID-19 on pregnancy and fetal outcomes in women with multiple sclerosis.
Mult Scler
; 30(6): 707-713, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38456445
2.
Therapeutic choices and disease activity after 2 years of treatment with cladribine: An Italian multicenter study (CladStop).
Eur J Neurol
; 31(6): e16250, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38549186
3.
Symptomatic COVID-19 course and outcomes after three mRNA vaccine doses in multiple sclerosis patients treated with high-efficacy DMTs.
Mult Scler
; 29(7): 856-865, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37165941
4.
Preventive exercise attenuates IL-2-driven mood disorders in multiple sclerosis.
Neurobiol Dis
; 172: 105817, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35835361
5.
Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 2022 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36180219
6.
Cerebrospinal fluid levels of L-glutamate signal central inflammatory neurodegeneration in multiple sclerosis.
J Neurochem
; 159(5): 857-866, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34547109
7.
Operationalization of a frailty index in patients with multiple sclerosis: A cross-sectional investigation.
Mult Scler
; 27(12): 1939-1947, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33565913
8.
Defining the course of tumefactive multiple sclerosis: A large retrospective multicentre study.
Eur J Neurol
; 28(4): 1299-1307, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33305459
9.
Pegylated interferon beta-1a (Plegridy) Italian real-world experience: a Delphi analysis of injection-site reaction and flu-like symptom management.
Neurol Sci
; 42(4): 1515-1521, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33439393
10.
Obesity worsens central inflammation and disability in multiple sclerosis.
Mult Scler
; 26(10): 1237-1246, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31161863
11.
Abortion induces reactivation of inflammation in relapsing-remitting multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 89(12): 1272-1278, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29970387
12.
mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 93(4): 448-450, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34408003
13.
Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis.
J Neuroinflammation
; 13(1): 207, 2016 08 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-27566665
14.
Interaction between interleukin-1ß and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis.
J Neuroinflammation
; 13(1): 231, 2016 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27589957
15.
Correction to: Pegylated interferon beta-1a (Plegridy) Italian real-world experience: a Delphi analysis of injection-site reaction and flu-like symptom management.
Neurol Sci
; 42(4): 1637, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33483887
16.
Ocrelizumab and ofatumumab comparison: an Italian real-world propensity score matched study.
J Neurol
; 2024 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38704488
17.
Treatment modifiers across different regimens of natalizumab treatment in MS: An Italian real-world experience.
Neurotherapeutics
; 21(3): e00338, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38413275
18.
SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose.
J Neurol
; 271(1): 24-31, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37922069
19.
NEDA-3 achievement in early highly active relapsing remitting multiple sclerosis patients treated with Ocrelizumab or Natalizumab.
Mult Scler Relat Disord
; 87: 105594, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38718748
20.
The role of ethnicity and native-country income in multiple sclerosis: the Italian multicentre study (MS-MigIT).
J Neurol
; 271(5): 2182-2194, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38366072